Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Bioharvest Sciences (BHST) Shares Outstanding (2023 - 2025)

Bioharvest Sciences has reported Shares Outstanding over the past 3 years, most recently at $22.7 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 30.81% year-over-year to $22.7 million; the TTM value through Dec 2025 reached $22.7 million, up 30.81%, while the annual FY2025 figure was $22.7 million, 30.81% up from the prior year.
  • Shares Outstanding was $22.7 million for Q4 2025 at Bioharvest Sciences, up from $17.3 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $22.7 million in Q4 2025 and bottomed at $13.7 million in Q4 2023.
  • The 3-year median for Shares Outstanding is $17.3 million (2024), against an average of $17.9 million.
  • Year-over-year, Shares Outstanding grew 26.69% in 2024 and then surged 30.81% in 2025.
  • Over 3 years, Shares Outstanding stood at $13.7 million in 2023, then increased by 26.69% to $17.3 million in 2024, then surged by 30.81% to $22.7 million in 2025.
  • The last three reported values for Shares Outstanding were $22.7 million (Q4 2025), $17.3 million (Q4 2024), and $13.7 million (Q4 2023) per Business Quant data.